Cliff Asness’s Trillium Therapeutics Inc. TRIL Stock Holding History

Cliff Asness’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,895	Closed	-$209K	–	2342
2021 Q3	$209K	Buy	+11,895	New	+$139K	﹤0.01%	2143

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Cliff Asness's TRIL Position: Q4 2021 in Review

Cliff Asness sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 11,895 shares — an estimated $209K sold.

Cliff Asness first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $209K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Cliff Asness reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Cliff Asness sold 11,895 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $209K.
Cliff Asness first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Cliff Asness's Trillium Therapeutics Inc. position peaked at $209K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on AQR Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.